ZyVersa (ZVSA) via Larkspur Health (LSPR) deck

ZyVersa is a clinical-stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs.

Debarshi Ghosh

This post is for subscribers only

Subscribe

Already have an account? Log in